Skip to content

13F-HR filed by SECTOR GAMMA AS

SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2013-06-30, filed 2013-08-14, with 33 holding rows worth $342,859,000.

Accession
0001140361-13-032340
Filed
2013-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2013

A holdings report, 33 entries on the cover page, a total value of $342,859,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $342,859,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
FOREST LABS INC345838106COM902,000$36,982,000thousands by filing date
Johnson & Johnson478160104COM385,500$33,099,000thousands by filing date
Boston Scientific Corporation101137107COM3,557,000$32,973,000thousands by filing date
Eli Lilly and Company532457108COM545,407$26,790,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM406,000$19,163,000thousands by filing date
BAXTER INTL INC071813109COM256,500$17,768,000thousands by filing date
CUBIST PHARMACEUTICALS INC229678107COM289,442$13,977,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR339,000$13,289,000thousands by filing date
AUXILIUM PHARMACEUTICALS05334D107COMMON STOCK684,724$11,388,000thousands by filing date
ONYX PHARMACEUTICALS INC683399109COM129,815$11,271,000thousands by filing date
ILLUMINA INC452327109COM131,000$9,804,000thousands by filing date
SALIX PHARMACEUTICALS INC795435106COM147,001$9,724,000thousands by filing date
HOSPIRA INC441060100COM228,000$8,735,000thousands by filing date
MEDICINES CO584688105COM274,750$8,451,000thousands by filing date
MASIMO CORP COM574795100Stock385,991$8,183,000thousands by filing date
REVVITY INC714046109COM242,000$7,865,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM95,300$7,630,000thousands by filing date
LIFEPOINT HEALTH INC53219L109COM147,800$7,219,000thousands by filing date
EXPRESS SCRIPTS HLDG CO30219G108COM113,000$6,977,000thousands by filing date
RESMED INC COM761152107Stock141,770$6,398,000thousands by filing date
AGILENT TECHNOLOGIES INC COM00846U101Stock148,000$6,328,000thousands by filing date
THORATEC CORP885175307COM200,000$6,262,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO60,000$5,707,000thousands by filing date
OPTIMER PHARMACEUTICALS INC68401H104COM341,393$4,940,000thousands by filing date
ACCENDRA HEALTH INC690732102COM139,384$4,715,000thousands by filing date
BIO RAD LABS INC090572207CL A37,000$4,151,000thousands by filing date
ALLERGAN INC018490102COM43,000$3,622,000thousands by filing date
UnitedHealth Group Inc91324P102COM40,000$2,619,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM165,000$2,485,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock32,310$2,127,000thousands by filing date
DENDREON CORP24823Q107COM345,000$1,421,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM5,000$423,000thousands by filing date
SPECTRUM PHARMACEUTICALS INC84763A108COM50,000$373,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-13-032340this filing2013-08-14acceptance time not in the bulk data set